How much profit has Medicover made this year?
Medicover has made 33.41 M EUR this year.
Medicover Net Income 2025
Medicover Net Income
33.41 M EUR
Ticker
MCOV B.ST
ISIN
SE0009778848
WKN
A2DRQV
In 2025, Medicover's profit amounted to 33.41 M EUR, a 164.71% increase from the 12.62 M EUR profit recorded in the previous year.
The Medicover Net Income history
| YEAR | NET INCOME (undefined EUR) |
|---|---|
| 2029e | - |
| 2028e | 70.06 |
| 2027e | 61.62 |
| 2026e | 48.63 |
| 2025e | 33.41 |
| 2024e | 12.62 |
| 2023 | 17.6 |
| 2022 | 12.1 |
| 2021 | 101.8 |
| 2020 | 25.8 |
| 2019 | 22.5 |
| 2018 | 22.3 |
| 2017 | 18.7 |
| 2016 | 6.5 |
| 2015 | 9 |
Medicover Revenue, EBIT, Net Income SE0009778848 · A2DRQV
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Medicover, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medicover from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medicover’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Medicover. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Medicover’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Medicover’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medicover’s growth potential.
Medicover Revenue, EBIT and net profit per share
| Date | Medicover Revenue | Medicover EBIT | Medicover Net Income |
|---|---|---|---|
| 2029e | 4.35 B undefined | 325.51 M undefined | 0 undefined |
| 2028e | 3.41 B undefined | 241.77 M undefined | 70.06 M undefined |
| 2027e | 3.01 B undefined | 213.92 M undefined | 61.62 M undefined |
| 2026e | 2.71 B undefined | 174.92 M undefined | 48.63 M undefined |
| 2025e | 2.39 B undefined | 135.14 M undefined | 33.41 M undefined |
| 2024e | 2.09 B undefined | 77.82 M undefined | 12.62 M undefined |
| 2023 | 1.75 B undefined | 61.9 M undefined | 17.6 M undefined |
| 2022 | 1.51 B undefined | 69 M undefined | 12.1 M undefined |
| 2021 | 1.38 B undefined | 159.4 M undefined | 101.8 M undefined |
| 2020 | 997.8 M undefined | 66.5 M undefined | 25.8 M undefined |
| 2019 | 844.4 M undefined | 47.3 M undefined | 22.5 M undefined |
| 2018 | 671.6 M undefined | 33.7 M undefined | 22.3 M undefined |
| 2017 | 580.2 M undefined | 28.8 M undefined | 18.7 M undefined |
| 2016 | 497.3 M undefined | 21.1 M undefined | 6.5 M undefined |
| 2015 | 415.6 M undefined | 21.5 M undefined | 9 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2015 | 415.6 M EUR | 21.5 M EUR | 9 M EUR |
| 2016 | 497.3 M EUR | 21.1 M EUR | 6.5 M EUR |
| 2017 | 580.2 M EUR | 28.8 M EUR | 18.7 M EUR |
| 2018 | 671.6 M EUR | 33.7 M EUR | 22.3 M EUR |
| 2019 | 844.4 M EUR | 47.3 M EUR | 22.5 M EUR |
| 2020 | 997.8 M EUR | 66.5 M EUR | 25.8 M EUR |
| 2021 | 1.38 B EUR | 159.4 M EUR | 101.8 M EUR |
| 2022 | 1.51 B EUR | 69 M EUR | 12.1 M EUR |
| 2023 | 1.75 B EUR | 61.9 M EUR | 17.6 M EUR |
| 2024e | 2.09 B EUR | 77.82 M EUR | 12.62 M EUR |
| 2025e | 2.39 B EUR | 135.14 M EUR | 33.41 M EUR |
| 2026e | 2.71 B EUR | 174.92 M EUR | 48.63 M EUR |
| 2027e | 3.01 B EUR | 213.92 M EUR | 61.62 M EUR |
| 2028e | 3.41 B EUR | 241.77 M EUR | 70.06 M EUR |
| 2029e | 4.35 B EUR | 325.51 M EUR | 0 EUR |
Medicover stock margins SE0009778848 · A2DRQV
The Medicover margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medicover. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medicover.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Medicover's sales revenue. A higher gross margin percentage indicates that the Medicover retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Medicover's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Medicover's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medicover's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medicover. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medicover's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Medicover Margin History
| Medicover Gross margin | Medicover Profit margin | Medicover EBIT margin | Medicover Profit margin |
|---|---|---|---|
| 2029e | 20.58 % | 7.48 % | 0 % |
| 2028e | 20.58 % | 7.09 % | 2.05 % |
| 2027e | 20.58 % | 7.11 % | 2.05 % |
| 2026e | 20.58 % | 6.45 % | 1.79 % |
| 2025e | 20.58 % | 5.65 % | 1.4 % |
| 2024e | 20.58 % | 3.73 % | 0.61 % |
| 2023 | 20.58 % | 3.54 % | 1.01 % |
| 2022 | 22.54 % | 4.57 % | 0.8 % |
| 2021 | 28.68 % | 11.57 % | 7.39 % |
| 2020 | 26.48 % | 6.66 % | 2.59 % |
| 2019 | 24.55 % | 5.6 % | 2.66 % |
| 2018 | 24.46 % | 5.02 % | 3.32 % |
| 2017 | 24.47 % | 4.96 % | 3.22 % |
| 2016 | 24.13 % | 4.24 % | 1.31 % |
| 2015 | 24.23 % | 5.17 % | 2.17 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2015 | 24.23 % | 5.17 % | 2.17 % |
| 2016 | 24.13 % | 4.24 % | 1.31 % |
| 2017 | 24.47 % | 4.96 % | 3.22 % |
| 2018 | 24.46 % | 5.02 % | 3.32 % |
| 2019 | 24.55 % | 5.6 % | 2.66 % |
| 2020 | 26.48 % | 6.66 % | 2.59 % |
| 2021 | 28.68 % | 11.57 % | 7.39 % |
| 2022 | 22.54 % | 4.57 % | 0.8 % |
| 2023 | 20.58 % | 3.54 % | 1.01 % |
| 2024e | 20.58 % | 3.73 % | 0.61 % |
| 2025e | 20.58 % | 5.65 % | 1.4 % |
| 2026e | 20.58 % | 6.45 % | 1.79 % |
| 2027e | 20.58 % | 7.11 % | 2.05 % |
| 2028e | 20.58 % | 7.09 % | 2.05 % |
| 2029e | 20.58 % | 7.48 % | 0 % |
Medicover Aktienanalyse
What does Medicover do?
Medicover AB is a leading healthcare company in Europe with its headquarters in Stockholm, Sweden. The company was founded in 1995 by Fredrik Rågmark with the aim of providing high-quality medical care for patients. Medicover's business model is based on an integrated chain of healthcare services. This includes doctor's offices, specialists, diagnostic centers, hospitals, laboratories, health centers, and nursing services. The company operates in Poland, Romania, Hungary, Germany, Ukraine, and Belarus, and offers a wide range of healthcare services. The main sectors of Medicover include healthcare services for individuals and businesses, as well as the use of cutting-edge technologies and data analysis to improve patient care. The company offers a variety of services in the areas of prevention, diagnosis, and therapy, including laboratory tests, imaging, health checks, medical advice, and treatment of acute and chronic diseases. In the field of corporate services, Medicover offers occupational medicine, corporate health management, as well as health programs and training for employees of companies. This helps promote the health and well-being of employees while achieving higher productivity and efficiency. Products offered by Medicover include insurance services, hospital services, travel medicine, vaccinations, child care, and family planning. The company also offers specialized programs for patients with chronic diseases such as diabetes, hypertension, and cardiovascular diseases. An important component of Medicover's business model is the use of data analysis and technology to improve patient care. The company leverages the latest innovations in medical technology such as telemedicine, electronic health records, and mobile applications to enable faster and more effective access to healthcare. With a strong focus on quality and customer satisfaction, Medicover has become one of the leading healthcare companies in Europe. The company employs over 25,000 employees and serves over 6 million patients per year. In summary, Medicover is an innovative and integrated company in the healthcare industry, specializing in providing high-quality healthcare services and utilizing advanced technologies and data analysis to improve patient care. Medicover ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Medicover's Profit Margins
The profit margins of Medicover represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Medicover's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Medicover's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Medicover's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Medicover’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Medicover stock
How has the profit developed compared to last year?
The profit has increased by 164.71% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Medicover publish its earnings?
Medicover publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Medicover?
The profits of Medicover are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Medicover?
You can learn more about the earnings of Medicover by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Medicover pay?
Over the past 12 months, Medicover paid a dividend of 0.12 EUR . This corresponds to a dividend yield of about 0.65 %. For the coming 12 months, Medicover is expected to pay a dividend of 0.12 EUR.
What is the dividend yield of Medicover?
The current dividend yield of Medicover is 0.65 %.
When does Medicover pay dividends?
Medicover pays a quarterly dividend. This is distributed in the months of May, May, May, May.
How secure is the dividend of Medicover?
Medicover paid dividends every year for the past 0 years.
What is the dividend of Medicover?
For the upcoming 12 months, dividends amounting to 0.12 EUR are expected. This corresponds to a dividend yield of 0.65 %.
In which sector is Medicover located?
Medicover is assigned to the 'Health' sector.
Wann musste ich die Aktien von Medicover kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Medicover from 5/8/2024 amounting to 0.12 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.
When did Medicover pay the last dividend?
The last dividend was paid out on 5/8/2024.
What was the dividend of Medicover in the year 2024?
In the year 2024, Medicover distributed 0.12 EUR as dividends.
In which currency does Medicover pay out the dividend?
The dividends of Medicover are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Medicover
Our stock analysis for Medicover Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medicover Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.